摘要
目的分析术前接受经导管肝动脉化疗栓塞(transcatheter arterial chemoembolization,TACE)肝癌患者的预后。方法回顾性总结139例术前接受TACE和156例单纯切除肝癌患者的临床资料,分层分析两组患者生存率的差异。结果术前TACE组和单纯切除组肝癌患者的总生存率无显著性差异,按临床病理特征进行分层比较,对于高侵袭性肝癌(肝内播散、癌栓、肿瘤分化差),术前TACE组患者的生存率明显高于相对应的单纯切除组,差异有统计学意义(P<0.05)。结论术前TACE并不能提高所有肝癌患者的生存率,但可以明显改善高侵袭性肝癌患者的生存预后。
Objective To evaluate prognosis of HCC patients underwent preoperative transcatheter arterial chemoembolization （TACE）. Methods Clinic pathologic datum of HCC patients were retrospectively reviewed, which were divided into TACE group （Group A, 139 cases） and non-TACE group （Group B, 156 cases）. The survival rates of two groups were compared. Results There were no significant differences between two groups. In patients with disseminated nodules, ductal invasion and poorly differentiated tumor, The survival rates were significantly higher in TACE group than non-TACE group, respectively （P〈0.05）. Conclusion Pre- operative TACE is not suitable for all patients of HCC. The HCC patients with disseminated nodules, ductal invasion and poorly differentiated tumor were more benefit from preoperative TACE.
出处
《中华普通外科学文献（电子版）》
2008年第3期31-34,共4页
Chinese Archives of General Surgery(Electronic Edition)
关键词
肝肿瘤
TACE
预后
生存分析
Carcinoma, hepatocellular
TACE
Prognosis
Survival analysis
